13.75
price down icon0.79%   -0.11
 
loading

Celcuity Inc Aktie (CELC) Neueste Nachrichten

pulisher
03:34 AM

What analysts say about Celcuity Inc. stockConsistently profitable trades - Jammu Links News

03:34 AM
pulisher
02:59 AM

Celcuity Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Jammu Links News

02:59 AM
pulisher
Jul 15, 2025

What makes Celcuity Inc. stock price move sharplyFree Elite Traders Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Celcuity Inc. stock performs during market volatilityBreakout Momentum Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Celcuity Inc. stock attracts strong analyst attentionProven High Yield Signals - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

How To Trade (CELC) - news.stocktradersdaily.com

Jul 14, 2025
pulisher
Jul 14, 2025

Celcuity Soars 17.16% on New Patent for Breast Cancer Drug - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

Celcuity receives U.S. patent for gedatolisib dosing regimen - Investing.com

Jul 14, 2025
pulisher
Jul 14, 2025

Celcuity Receives New Patent for Gedatolisib - MarketScreener

Jul 14, 2025
pulisher
Jul 14, 2025

Celcuity receives U.S. patent for gedatolisib dosing regimen By Investing.com - Investing.com South Africa

Jul 14, 2025
pulisher
Jul 14, 2025

Celcuity Announces Issuance of New Patent for Gedatolisib that Extends Patent Exclusivity into 2042 - The Manila Times

Jul 14, 2025
pulisher
Jul 11, 2025

Celcuity, Inc. (NASDAQ:CELC) Receives $28.40 Average Target Price from Analysts - Defense World

Jul 11, 2025
pulisher
Jul 10, 2025

Celcuity projects $2B revenue potential for gedatolisib in second-line breast cancer market - MSN

Jul 10, 2025
pulisher
Jul 09, 2025

Celcuity(CELC) Shares Soar 4.70% on Phase 2 Trial Success - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

Amid NCI Budget Fears, Emerging Oncology Stocks Gain Attention - PentictonNow

Jul 08, 2025
pulisher
Jul 04, 2025

Learn to Evaluate (CELC) using the Charts - news.stocktradersdaily.com

Jul 04, 2025
pulisher
Jul 02, 2025

Stifel Initiates Celcuity(CELC.US) With Buy Rating, Announces Target Price $30 - 富途牛牛

Jul 02, 2025
pulisher
Jul 01, 2025

Celcuity (NASDAQ:CELC) Given Buy Rating at Needham & Company LLC - Defense World

Jul 01, 2025
pulisher
Jun 30, 2025

Celcuity Announces Promising Phase 1 Gedatolisib Results - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

Celcuity reports positive early data for gedatolisib in cancer trials - Investing.com Australia

Jun 30, 2025
pulisher
Jun 24, 2025

Rhumbline Advisers Has $427,000 Stock Position in Celcuity, Inc. (NASDAQ:CELC) - Defense World

Jun 24, 2025
pulisher
Jun 16, 2025

Analysts Set Celcuity Inc. (NASDAQ:CELC) Price Target at $30.80 - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Wealth Enhancement Advisory Services LLC Grows Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Stocks in play: Roots Corp. - The Globe and Mail

Jun 13, 2025
pulisher
Jun 13, 2025

(CELC) Trading Advice - news.stocktradersdaily.com

Jun 13, 2025
pulisher
Jun 11, 2025

Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - Revista ADVFN

Jun 11, 2025
pulisher
Jun 10, 2025

Cisco Powers AI-Ready Data Centers, From Hyperscale to Enterprise - The Globe and Mail

Jun 10, 2025
pulisher
Jun 09, 2025

Millennium Management LLC Has $519,000 Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Has $679,000 Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Nuveen Asset Management LLC Grows Position in Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Ballard announces 1.5 MW fuel cell engine order for Sierra Northern Railway - The Globe and Mail

Jun 05, 2025
pulisher
Jun 04, 2025

Citadel Advisors LLC Buys New Stake in HUHUTECH International Group Inc. (NASDAQ:HUHU) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Advisers LP Decreases Stock Position in Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Celcuity Inc. (NASDAQ:CELC) Shares Sold by BNP Paribas Financial Markets - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Celcuity Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 02, 2025

BMO Lowers Fees on Asset Allocation ETFs to Deliver Greater Value to Investors - The Globe and Mail

Jun 02, 2025
pulisher
Jun 01, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $258,000 Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Deutsche Bank AG Purchases 9,174 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Cetera Investment Advisers Trims Position in Franklin Limited Duration Income Trust (NYSEAMERICAN:FTF) - Defense World

May 31, 2025
pulisher
May 31, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by Cetera Investment Advisers - Defense World

May 31, 2025
pulisher
May 31, 2025

BlackRock Floating Rate Income Strategies Fund, Inc. (NYSE:FRA) Shares Acquired by Cetera Investment Advisers - Defense World

May 31, 2025
pulisher
May 31, 2025

Schwab U.S. REIT ETF (NYSEARCA:SCHH) Stock Holdings Raised by Bank of America Corp DE - Defense World

May 31, 2025
pulisher
May 31, 2025

Citadel Advisors LLC Sells 24,240 Shares of Goldman Sachs Access Inflation Protected USD Bond ETF (BATS:GTIP) - Defense World

May 31, 2025
pulisher
May 31, 2025

BNP Paribas Financial Markets Sells 19,586 Shares of NovaGold Resources Inc. (NYSEAMERICAN:NG) - Defense World

May 31, 2025
pulisher
May 30, 2025

Bank of America Corp DE Has $3.77 Million Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World

May 30, 2025
pulisher
May 29, 2025

H-CYTE (OTCMKTS:HCYTD) Stock Price Down 49.5% – What’s Next? - Defense World

May 29, 2025
pulisher
May 28, 2025

Celcuity at TD Cowen’s Oncology Summit: Exploring Gadotelisib’s Potential By Investing.com - Investing.com Canada

May 28, 2025
pulisher
May 28, 2025

Celcuity at TD Cowen’s Oncology Summit: Exploring Gadotelisib’s Potential - Investing.com India

May 28, 2025
pulisher
May 27, 2025

Tourmaline Oil (OTCMKTS:TRMLF) Stock Price Up 1.9% – What’s Next? - Defense World

May 27, 2025
pulisher
May 27, 2025

AIB Group (OTCMKTS:AIBRF) Stock Price Up 0.3% – Here’s Why - Defense World

May 27, 2025
pulisher
May 27, 2025

FIBRA Prologis (OTCMKTS:FBBPF) Stock Price Down 1.1% – Here’s Why - Defense World

May 27, 2025
pulisher
May 27, 2025

HELLA GmbH & Co. KGaA (OTCMKTS:HLLGY) Shares Down 1.1% – Here’s What Happened - Defense World

May 27, 2025
pulisher
May 27, 2025

Secure Energy Services (OTCMKTS:SECYF) Shares Up 3.2% – What’s Next? - Defense World

May 27, 2025
pulisher
May 27, 2025

Husky Energy (OTCMKTS:HUSKF) Stock Price Up 7% – Still a Buy? - Defense World

May 27, 2025
pulisher
May 27, 2025

Exicure (NASDAQ:XCUR) Trading Down 4.5% – Here’s Why - Defense World

May 27, 2025
pulisher
May 27, 2025

Namaste Technologies (CVE:N) Trading 6.9% Higher – Time to Buy? - Defense World

May 27, 2025
pulisher
May 27, 2025

Virtus InfraCap U.S. Preferred Stock ETF (NYSEARCA:PFFA) Shares Down 0.1% – Here’s What Happened - Defense World

May 27, 2025
pulisher
May 27, 2025

Lundin Gold (OTCMKTS:FTMNF) Shares Up 4.3% – What’s Next? - Defense World

May 27, 2025
pulisher
May 27, 2025

Roche (OTCMKTS:RHHVF) Stock Price Up 0.4% – Still a Buy? - Defense World

May 27, 2025
pulisher
May 27, 2025

GraniteShares XOUT U.S. Large Cap ETF (NYSEARCA:XOUT) Trading Down 1% – Here’s What Happened - Defense World

May 27, 2025
pulisher
May 27, 2025

FinServ Acquisition (OTCMKTS:FSRVU) Trading 7.9% Higher – Still a Buy? - Defense World

May 27, 2025
pulisher
May 25, 2025

D. E. Shaw & Co. Inc. Sells 13,666 Shares of Tompkins Financial Co. (NYSEAMERICAN:TMP) - Defense World

May 25, 2025
pulisher
May 24, 2025

Ameriprise Financial Inc. Has $5.85 Million Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World

May 24, 2025
$22.01
price up icon 0.64%
$35.47
price down icon 0.37%
$104.17
price down icon 0.40%
$27.63
price down icon 2.26%
$111.04
price down icon 1.29%
biotechnology ONC
$290.35
price up icon 4.01%
Kapitalisierung:     |  Volumen (24h):